المؤلفون: Daryl Ming Zhe Cheah, Sanjay de Mel, Masturah Bte Mohd Rashid, Jing Quan Lim, Edward Kai-Hua Chow, Choon Kiat Ong, Siok Bian Ng, Soo Yong Tan, Chun Tsu Lee, Soon Thye Lim, Joanne Lee, Wee Joo Chng, Xin Liu, Hoi-Yin Loi, Yi Ching Yuen, Tiffany Tang, Xi Yun Zhang, Li Mei Poon, Yurike Laurensia, Lip Kun Tan, Dachuan Huang, Anand D. Jeyasekharan, Esther H. L. Chan, Jasmine Goh, Esther Kam Yin Wong, Wan Lu Pang, Yen Lin Chee, Burton Kuan Hui Chia

المصدر: Blood Cancer Journal, Vol 10, Iss 1, Pp 1-5 (2020)
Blood Cancer Journal

مصطلحات موضوعية: Drug, business.industry, Refractory T-Cell Lymphoma, media_common.quotation_subject, Complete remission, Hematology, Translational research, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Lymphoma, Oncology, Correspondence, Cancer research, Medicine, T-cell lymphoma, business, Ex vivo, media_common

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74131b60825389c7226e8da1c9dcbc74Test
http://link.springer.com/article/10.1038/s41408-020-0276-7Test

المؤلفون: Nicolas Daguindau, Hassan Farhat, Vincent Camus, Sabine Tricot, Philippe Gaulard, Catherine Thieblemont, Franck Morschhauser, Thierry Lamy De La Chapelle, Emmanuel Bachy, Laurence de Leval, Kamel Laribi, Marc André, Maya Hacini, Adrien Chauchet, Bernard Drenou, Anne Banos, Richard Delarue, Hacene Zerazhi, Guillaume Cartron, Steven Le Gouill, Marie Maerevoet, Nicole Straetmans, Sylvia Snauwaert, Olivier Tournilhac, Emmanuelle Nicolas-Virelizier, Emmanuel Gyan, Céline Bossard, Caroline Delette, Kamal Bouabdallah, Stéphanie Guidez, David Sibon, Marie Parrens, Gandhi Damaj, Pierre Feugier, Jehan Dupuis, Loic Ysebaert

المصدر: Blood. 136:15-16

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Refractory T-Cell Lymphoma, Immunology, Phases of clinical research, Cell Biology, Hematology, Biochemistry, Gemcitabine, Internal medicine, medicine, business, Brentuximab vedotin, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ffcc977646197f12f118b6259e87bedfTest
https://doi.org/10.1182/blood-2020-139224Test

المؤلفون: Fujian Cancer Hospital, Zhangzhou Affiliated Hospital of Fujian Medical University, Dongguan People's Hospital, Huizhou Municipal Central Hospital, The First Affiliated Hospital with Nanjing Medical University, Sun Yat-sen University, Shanxi Province Cancer Hospital

المساهمون: Bing, Xu, Principal Investigator

المصدر: A Multicenter, Prospective and Single-arm Clinical Study on the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma (R/R PTCL) With Chidamide and Duvalisib

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06151106Test

المصدر: An Open-label, Multi-center, Non-randomized Phase I Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ONO-4685 Given as Monotherapy in Patients With Relapsed or Refractory T Cell Lymphoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05079282Test

المؤلفون: Roche Pharma AG, Allcyte GmbH

المساهمون: Philipp Staber, MD, PhD, Assoc. Prof. Priv.-Doz. Dr.med.univ. Philipp Staber

المصدر: Snder B, Vlader G Krall N, Mra K, Schmolke AS, Kornauth C, Lopez de la Fuente O, ChoHS, van der Kouwe E, Gultek S, Kaznka L, Benzahn JW, Hoermann G, Prutsch N, Merkel O, Rgler A, Sabler M, JeryczynskG, Mayerhoefer ME, Sonsch-Klupp Ocko K, Felberbauer F, Mullauer L, Prager GW, Korkmaz B, Kenner L, Sperr WR, Kralovs R, Gslger H, Valent P, Kubek S, Jager U, Staber PB, SupertFurga G. age-based ex-vo drug screeng for patnts wh aggresse haematologal malnancs: ter results from a sgle-arm, open-label, pot study. Lancet Haematol. 2017 Dec;4(12):e595-e606. do 10.1016/S2352-3026(17)30208-9. Epub 2017 Nov 15.
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies: Next Generation Personal Hematology

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04470947Test

المصدر: A Phase II, Open Label, Multicenter Trial of Daratumumab in Combination With Gemcitabine, Dexamethasone and Cisplatin (D-GDP) in Patients With Relapsed/Refractory CD38 Positive Peripheral T-cell Lymphoma Not Otherwise Specified (PTCL-NOS), Angioimmunoblastic T-cell Lymphoma (AITL) and Other Nodal Lymphomas of TFH Cell Origin

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04251065Test

المؤلفون: National Cancer Institute (NCI)

المصدر: Pilot Study of CPI-613, in Combination With Bendamustine, in Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04217317Test

المؤلفون: iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital

المصدر: CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04162340Test

المؤلفون: Leadiant Biosciences, Inc.

المساهمون: Philippe Armand, MD, PhD, Principal Investigator

المصدر: A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01878708Test

المؤلفون: Ohio State University, Pharmacyclics LLC., Janssen Biotech, Inc.

المصدر: A Multicenter Phase I Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02309580Test

Other URLs: http://www.mskcc.orgTest/